Wegovy: The New Standard in Weight Loss Medication

FDA-approved, clinically proven, and transforming expectations for obesity care. See how Wegovy can fit into your health journey.
See Side Effects How Well Does It Work?
C
Clinically Proven Results
Wegovy consistently outperformed placebo in major trials, with participants losing an average of 15% body weight.
L
Long-Term Health Benefits
Reduces risk factors for type 2 diabetes and cardiovascular disease while supporting lasting weight control.
S
Simple Once-Weekly Admin
A single injection per week—no daily scheduling. Self-administered with a discreet, easy-to-use pen.
A
Approved for Adults with Obesity
Recommended for adults with BMI ≥30 (or ≥27 with comorbidities). Covered by many insurance plans.
See also: prescription weight loss drugs obesity medications liraglutide
GLP-1 Receptor Agonist

What is Wegovy?

Wegovy is a prescription injectable medication designed to help adults manage chronic weight issues. Developed by Novo Nordisk, it belongs to the GLP-1 receptor agonist class—the same family as semaglutide and liraglutide. Wegovy is unique because it uses a higher dose of semaglutide, which amplifies its weight loss effect compared to treatments made primarily for diabetes.

Approved by the FDA in June 2021, Wegovy marked a pivotal change in how clinicians approach obesity. Unlike older appetite suppressants, it works by mimicking a naturally occurring hormone (GLP-1) that helps regulate hunger and fullness in the brain.

  • Once-weekly subcutaneous injection (in the abdomen, thigh, or upper arm)
  • Specifically indicated for chronic weight management
  • Often covered by insurance with prior authorization
FDA Approval: 2021

How Does Wegovy Work in the Body?

Wegovy acts on the brain’s appetite centers, decreasing hunger and increasing feelings of fullness after meals. GLP-1 receptor agonists, like semaglutide, also slow gastric emptying—meaning food stays in the stomach a bit longer, which further enhances satiety. As a result, most people find themselves eating less without the constant struggle of willpower.

Clinical trials of Wegovy showed remarkable efficacy: Over 68 weeks, adults using Wegovy lost an average of 15% of their initial body weight versus only 2.4% with placebo. Importantly, this was achieved alongside lifestyle interventions, not in place of them—diet and activity remain part of every successful plan.

  1. Reduces appetite by mimicking GLP-1 hormone action
  2. Promotes fullness, so smaller portions feel satisfying
  3. May improve blood sugar control for those with prediabetes
Indications & Eligibility

Who is Wegovy For?

Wegovy is indicated for adults with a body mass index (BMI) of 30 or greater, or 27 and above if certain weight-related conditions—like high blood pressure, type 2 diabetes, or high cholesterol—are present. It’s not meant for casual or cosmetic weight loss, but for people facing real health risks due to excess weight.

  • BMI ≥30 (obesity), or ≥27 with at least one comorbidity
  • Not for use in people with a history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • Pregnant or breastfeeding women should not use Wegovy

If you’re considering other pharmaceutical options, explore our weight loss drugs comparison page for alternatives and detailed safety profiles.

Risks & Monitoring

Side Effects and Safety Considerations

Like all prescription medications, Wegovy comes with possible risks. The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal pain. For most, these symptoms are mild to moderate and diminish over time.

  • Nausea (most common, especially at dose escalation)
  • Constipation or diarrhea
  • Rarely: pancreatitis, gallbladder issues, or kidney problems

Monitoring is essential. Your healthcare provider will usually start you on a low dose and gradually increase it over four months to minimize side effects. Routine lab tests (such as blood glucose and kidney function) are often recommended.

Serious allergic reactions are rare, but you should seek immediate care for symptoms such as shortness of breath, swelling, or a rash after an injection.

Real-World Use

Access, Adherence, and Practical Tips

Wegovy requires a prescription and is typically managed by primary care, internal medicine, or obesity specialists. Patients often self-inject at home after training. Set a weekly reminder—for instance, every Sunday morning—to help build the habit.

Cost varies widely depending on insurance coverage. Some plans require prior authorization, with monthly copays ranging from $25 to $120, while others may not cover it at all (self-pay price is around $1350/month). Manufacturer savings cards and patient assistance programs can help reduce out-of-pocket costs for eligible individuals.

  • Store pens in the refrigerator until first use; travel with a cool pack if needed
  • Rotate injection sites to avoid skin irritation
  • Report any unusual symptoms to your provider promptly

For more information on related therapies, visit our pages on glp 1 medications and tirzepatide for head-to-head comparisons.

15%
Average Weight Loss
9 of 10
Saw ≥5% Weight Loss
2021
FDA Approval Year
2.4M+
U.S. Prescriptions Issued

Wegovy FAQ

How much weight can I expect to lose on Wegovy?
Clinical trials showed adults using Wegovy lost an average of 15% of their initial body weight after 68 weeks, compared with 2–3% using a placebo. Results do vary—some lose more, a few less—but most users who adhere to both medication and lifestyle changes see significant, sustained weight reduction.
What are the most common side effects of Wegovy?
The most frequently reported side effects are mild to moderate gastrointestinal symptoms: nausea, vomiting, diarrhea, constipation, and stomach pain. Starting with a low dose and gradually increasing can minimize these. They typically improve after the first month.
Who should not use Wegovy?
Wegovy is not recommended for people with a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2 (MEN 2), or those who are pregnant, breastfeeding, or under 18 years of age. Always discuss your full medical history with your provider.
Is Wegovy covered by insurance?
Coverage varies by insurer and plan. Many commercial insurance plans and some state Medicaid programs cover Wegovy for qualifying patients, though prior authorization is often required. Manufacturer savings programs may be available for those without coverage.
What happens if I stop taking Wegovy?
Most people will regain some or all of the lost weight if Wegovy is discontinued, especially if dietary and activity habits also lapse. The medication works while you use it—it doesn't "reset" metabolism permanently. Discuss long-term plans with your healthcare provider.
Start Your Wegovy Journey
Join the 2.4 million+ adults making healthier choices with medically guided weight loss. Secure your consultation—spots fill quickly.
See All Weight Loss Medications